Chapter 16. Management of Antiplatelet Therapy for Non-Cardiac Surgery

  1. Stephen D. Wiviott MD Assistant Professor Investigator
  1. Nisheeth Goel MD Interventional Cardiology Fellow1,
  2. John F. Canales MD2 and
  3. James J. Ferguson MD Cardiology Research3

Published Online: 19 FEB 2009

DOI: 10.1002/9781444303339.ch16

Antiplatelet Therapy In Ischemic Heart Disease

Antiplatelet Therapy In Ischemic Heart Disease

How to Cite

Goel, N., Canales, J. F. and Ferguson, J. J. (2008) Management of Antiplatelet Therapy for Non-Cardiac Surgery, in Antiplatelet Therapy In Ischemic Heart Disease (ed S. D. Wiviott), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303339.ch16

Editor Information

  1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, TIMI Study Group, Boston, MA, USA

Author Information

  1. 1

    Texas Heart Institute/Baylor College of Medicine, St. Luke's Episcopal Hospital Houston, TX, USA

  2. 2

    Cardiology Department, Texas Heart Institute, Baylor College of Medicine, St. Luke's Episcopal Hospital, Houston, Tx, USA

  3. 3

    St. Luke's Episcopal Hospital Houston, TX USA

Publication History

  1. Published Online: 19 FEB 2009
  2. Published Print: 28 NOV 2008

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman MD, FAHA

Series Editor Information

  1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, TIMI Study Group, Boston, MA, USA

ISBN Information

Print ISBN: 9781405176262

Online ISBN: 9781444303339

SEARCH

Keywords:

  • perioperative management of antiplatelet therapy;
  • percutaneous coronary intervention (PCI);
  • Clopidogrel for the Reduction of Events During Observation (CREDO) trial;
  • Drug-eluting stents (DES);
  • discontinuation of antiplatelet therapy and associated risks;
  • antiplatelet therapy in perioperative period;
  • perioperative management goals for patients implanted with coronary stents

Summary

This chapter contains sections titled:

  • Introduction

  • Rationale for antiplatelet therapy

  • Risks associated with discontinuation of antiplatelet therapy

  • Antiplatelet therapy in the perioperative period

  • Perioperative management of antiplatelet therapy in patients with coronary stents

  • Perioperative management of antiplatelet therapy in patients without coronary stents

  • Delaying surgery in recently stented patients

  • Conclusion

  • References